FRAT1 and FRAT2 are tumor promoting genes whereas VANGL1 is a tumor suppressor gene which involved in the Wnt/ß-catenin signaling pathway and thus posses as a molecular target of nobiletin. This evidence concerns the gene VANGL1 and neoplasm.